Olanzapine for chemotherapy-induced nausea and vomiting: systematic review and meta-analysis
Background: Chemotherapy induced nausea and vomiting (CINV) remains the most distressing event in patients receiving highly emetogenic chemotherapy (HEC) or moderately emetogenic chemotherapy (MEC). Objective: Therefore, this meta-analysis was conducted to evaluate the efficacy of olanzapine conta...
Main Authors: | Chelkeba L, Gidey K, Mamo A, Yohannes B, Matso T, Melaku T. |
---|---|
Format: | Article |
Language: | English |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2017-03-01
|
Series: | Pharmacy Practice |
Subjects: | |
Online Access: | http://www.pharmacypractice.org/journal/index.php/pp/article/view/877/495 |
Similar Items
-
Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience
by: Salihah N, et al.
Published: (2016-04-01) -
Assessment of the Adherence Rate of Acute Chemotherapy Induced Nausea and Vomiting Prophylaxis Regimens by Medical Team to NCCN Clinical Recommendations: Cross-Section Observation
by: Mohammad Mohammadzadeh, et al.
Published: (2021-04-01) -
Impact of Olanzapine on Refractory Chemotherapy-Induced Nausea and Vomiting: a Retrospective Study
by: Seibert, Laurel, et al.
Published: (2013) -
Postoperative nausea and vomiting
by: Young Eun Moon
Published: (2014-09-01) -
Clinical Observation of Olanzapine in Treatment of Nausea and Vomiting Caused by Opioid Analgesics
by: LI Daojun, et al.
Published: (2018-05-01)